PONTE VEDRA, Fla., May 08, 2026 (GLOBE NEWSWIRE) — Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today reported financial results for the first quarter ended March 31, 2026. Recent HighlightsGenerated revenue of $47.2 million in first quarter 2026 compared to $52.6 million in the same period in 2025.  Reported first quarter 2026 net loss of $(18.0) million and adjusted EBITDA of $(5.5) million in the first quarter 2026. Cash, cash equivalents, and marketable securities totaled $51.9 million as of March 31, 2026, representing an increase of $3.5 million from the Company’s balance of $48.4 million as of December 31, 2025, and compares to an increase of...

Quarterly net revenues of $237.5 million, an increase of 20.5% year-over-year Purified Cortrophin® Gel net revenues of $75.1 million, an increase of 42.1% year-over-year Quarterly GAAP net income available to common shareholders of $29.5 million; Quarterly adjusted non-GAAP EBITDA of $63.0 million, an increase of 24.1% year-over-year Diluted GAAP income per share of $1.28 and adjusted non-GAAP diluted earnings per share of $2.05 Raised 2026 total net revenue guidance to $1,080 million to $1,140 million, adjusted non-GAAP EBITDA to $285 million to $300 million, and adjusted non-GAAP diluted earnings per share to $9.19 to $9.69; reaffirmed 2026 Cortrophin Gel net revenue guidance of $540 million to $575 million $100 million share repurchase program authorized by Board of DirectorsPRINCETON, N.J., May 08, 2026 (GLOBE NEWSWIRE) —...

Revenue Increase of 23% Driven by Ramp Up of Long-Term Contracts Won in 2025; Enters Second Quarter with a Record Backlog of $273.3 Million VIENNA, Va., May 08, 2026 (GLOBE NEWSWIRE) — Castellum, Inc. (NYSE-American: CTM) (“Castellum” “CTM”, “we” or the “Company”), a cybersecurity, electronic warfare, and software services company focused on the federal government, today announced its financial results for the three-month period (“Q1”) ended March 31, 2026. Q1 2026 Financial HighlightsRevenues of $14.3 million, up 23% as compared to $11.7 million in Q1 2025. Gross profit of $5.1 million, up 11% as compared to $4.6 million in Q1 2025. Adjusted EBITDA* was $0.4 million, compared to $0.08 million in Q1 2025. Net loss was $0.4 million (or $0.00 per basic and diluted share), improved from a net loss of $1.2 million (or $0.01 per basic...

The Board of Directors of Kvika banki hf. is set to approve the financial statements of the Group for the first quarter of 2026 at a board meeting on Tuesday 12 May. The financial statements will subsequently be published after the domestic market has closed. A presentation for shareholders and market participants will be held at 08:30 on Wednesday, 13 May, at the Bank’s headquarters at Katrínartún 2, Reykjavík. At the meeting, Ármann Þorvaldsson, CEO, and Eiríkur Magnús Jensson, CFO, will present the Group’s financial results and Richard Beenstock, CEO of Kvika Limited, will provide an overview of the Bank’s UK operations. The presentation will be conducted in Icelandic and will be streamed live. Further, a recording of the meeting with English subtitles will later be made available on Kvika’s website. Meeting participants will be able...

FIRST-QUARTER RESULTS Both business units delivered solid results during the first quarter, despite lower activity levels due to harsh and prolonged winter weather.Revenue decreased 18% to DKK 2.2bn due to lower activity levels and the current phasing of the order portfolio, where several major projects make only modest contributions during their start-up phase. Operating profit (EBIT) decreased by 31% to DKK 67m due to lower activity levels and capacity utilisation. The EBIT margin remained solid at 3.1% despite the challenging weather conditions. Profit after tax from continuing operations was DKK 52m (2025: DKK 71m). Net profit was DKK 42m (2025: DKK 58m) after minor losses of DKK 10m (2025: DKK 13m) in discontinued operations following the completion of the sale and winding up of the international activities. Cash flows from operating...

High activity and strong financial performance AKVA group (“AKVA”) delivered high quarterly revenue in Q1 2026 of NOK 1,140 million, an increase of 13% compared to Q1 2025.  Record high quarterly EBITDA of NOK 153 million, an increase of NOK 40 million compared to Q1 2025. Strong order intake of NOK 1,493 million in the quarter and order backlog of NOK 2,830 million at the end of Q1 2026. A RAS contract with value of approx. NOK 200 million was awarded from Årdal Aqua AS in February. A smolt contract of approx. EUR 28 million was awarded from Laxey EHF in April. Four new barges for the international market were awarded in Q1 2026 with a total contract value estimated at EUR 6 million. Acquisition of remaining shares in Submerged AS, increasing ownership from 58% to 100%, was completed during Q1. A dividend of NOK 1 per share was paid...

AS Tallinna Vesi’s sales in the first quarter of 2026 were €17.99 million, which is an increase of 12.4% compared to the same period last year. Growth in sales was mostly driven by sales of construction services and changes in the price for water service related to increased investment.  In the first quarter, investments totalling €7.86 million were made, which is 16% more than in the same period of 2025. Aleksandr Timofejev, the CEO of Tallinna Vesi, said that in the first quarter, the company focused on strengthening operational continuity and preparing for the busy construction and renovation season in the upcoming summer. “Investments are crucial for ensuring the sustainability of the water infrastructure and for coping with changing climatic conditions – for example, the Kolde-Lahepea detention pond in North Tallinn is due to...

SATO Corporation, Interim Report 8 May 2026 at 9:00 am EET SATO Corporation Interim Report 1 January–31 March 2026: SATO’s growth continues This is a summary of SATO’s interim report for January–March, which has been published in full as an appendix to the release and at www.sato.fi/en. The figures in the report are unaudited. Summary for 1 Jan – 31 Mar 2026 (1 Jan – 31 Mar 2025)The economic occupancy rate was 95.3% (95.0). Net sales totalled EUR 80.1 million (77.2). Net rental income was EUR 46.2 million (46.8). Profit before taxes was EUR 17.1 million (18.3). The unrealised change in the fair value of investment propertiesincluded in the result was EUR 1.0 million (1.4). Housing investments amounted to EUR 105.5 million (3.9). Invested capital at the end of the review period was EUR 4,903.9 million (4,687.6). Return on invested capital...

Amsterdam, 8 May 2026 – Brunel International N.V. (Brunel; BRNL), a global specialist delivering customised project and workforce solutions to drive sustainable industry transformations through technology and talent, today announced its results for the first quarter 2026.  Q1 2026 HighlightsTotal Revenue of EUR 298.9 million, down 4% (up 1% organically) Gross Profit of EUR 53.4 million, down 5% (down 1% organically) Operating costs down by 5% (down 2% organically), supported by cost reduction program executed last year Underlying EBIT of EUR 7.9 million, down 5% (up 5% organically)Peter de Laat, CEO: “Our results for the first quarter of 2026 mark a first step from stabilisation towards recovery. After the usual slow start of the year, we quickly returned to the run rate of around EUR 300 million in revenue per quarter with increased...

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LRFIRST QUARTER | 2026Q1 2026 sales decreased by 2 % in local currencies1 to CHF 918 million with the Middle East conflict impacting Catalyst volumes and portfolio pruning affecting Care Chemicals; 0.5 % decline excluding portfolio pruning Q1 2026 EBITDA margin before exceptional items of 17.5 % decreased by 130 basis points compared to a strong Q1 2025 mainly due to the Middle East conflict and a one-off impacting Catalysts Q1 2026 free cash flow conversion improved by 12 percentage points to 54 % (LTM basis), achieved through effective net working capital management and continued disciplined Capex On track to achieve the remaining CHF 30 million of the total CHF 80 million performance improvement program savings (Investor Day 2024) already in 2026, with CHF 9 million achieved in the first...